Zulresso

Zulresso

  • March 2019 •
  • 17 pages •
  • Report ID: 5807971 •
  • Format: PDF
Zulresso is SAGE Therapeutics’ proprietary intravenous formulation of brexanolone, which is an allosteric modulator of both synaptic and extra-synaptic GABA-A receptors.